LY3537031
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LY3537031, covering 2025-12-04 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment [Phase 1]